A detailed history of Mather Group, Llc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Mather Group, Llc. holds 28,784 shares of ABBV stock, worth $4.75 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
28,784
Previous 61,485 53.19%
Holding current value
$4.75 Million
Previous $10.5 Million 46.1%
% of portfolio
0.07%
Previous 0.13%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$163.84 - $199.33 $5.36 Million - $6.52 Million
-32,701 Reduced 53.19%
28,784 $5.68 Million
Q2 2024

Jul 08, 2024

BUY
$154.79 - $180.76 $5.31 Million - $6.2 Million
34,287 Added 126.06%
61,485 $10.5 Million
Q1 2024

Apr 08, 2024

SELL
$159.82 - $182.1 $1.97 Million - $2.24 Million
-12,300 Reduced 31.14%
27,198 $4.95 Million
Q4 2023

Feb 05, 2024

BUY
$137.6 - $154.97 $245,891 - $276,931
1,787 Added 4.74%
39,498 $6.12 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $271,989 - $314,867
2,036 Added 5.71%
37,711 $5.62 Million
Q2 2023

Aug 08, 2023

BUY
$132.51 - $164.9 $113,561 - $141,319
857 Added 2.46%
35,675 $4.81 Million
Q1 2023

May 09, 2023

BUY
$144.61 - $166.54 $1.21 Million - $1.39 Million
8,355 Added 31.57%
34,818 $5.55 Million
Q4 2022

Mar 10, 2023

SELL
$138.31 - $165.87 $41,216 - $49,429
-298 Reduced 1.11%
26,463 $4.28 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $450,408 - $516,589
3,356 Added 14.34%
26,761 $3.59 Million
Q2 2022

Aug 16, 2022

BUY
$137.62 - $174.96 $56,424 - $71,733
410 Added 1.78%
23,405 $3.59 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $3.03 Million - $3.77 Million
22,995 New
22,995 $3.73 Million
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $1.47 Million - $1.98 Million
-18,206 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$85.91 - $100.83 $55,068 - $64,632
641 Added 3.65%
18,206 $1.6 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $1.29 Million - $1.72 Million
17,565 New
17,565 $1.73 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mather Group, Llc. Portfolio

Follow Mather Group, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.